Cargando…

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.

Authors carried out a review of 40 cases of recurrent and/or metastatic nasopharyngeal carcinoma (NPC) treated with cisplatin-based chemotherapy at the Division of Othorhinolaryngology and the Service of Chemotherapy of the University of Palermo between July 1984 and July 1992. All patients were tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebbia, V., Zerillo, G., Restivo, G., Speciale, R., Cupido, G., Lo Bue, P., Ingria, F., Gallina, S., Spatafora, G., Testa, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968311/ https://www.ncbi.nlm.nih.gov/pubmed/7686391

Ejemplares similares

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
por: Gebbia, V., et al.
Publicado: (1996)

Obstructive sleep apnoea syndrome (OSAS): effects on the vestibular system
por: GALLINA, S., et al.
Publicado: (2010)

Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma
por: Chan, Stephen L, et al.
Publicado: (2006)

Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
por: Hong, Shaodong, et al.
Publicado: (2016)

Chemotherapeutic Treatment of Priapism in Metastatic Rectal Cancer
por: Kitai, Y., et al.
Publicado: (2008)

Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
por: Colucci, G., et al.
Publicado: (1995)

Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review
por: Prawira, A, et al.
Publicado: (2017)

Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
por: Alshamsan, Bader, et al.
Publicado: (2022)

Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo
por: Chen, Thomas C., et al.
Publicado: (2015)

The immunohistochemical peptidergic expression of leptin is associated with recurrence of malignancy in laryngeal squamous cell carcinoma
por: GALLINA, S., et al.
Publicado: (2015)

Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
por: Colucci, G., et al.
Publicado: (1997)

An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
por: Péron, Julien, et al.
Publicado: (2014)

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
por: Fagone, Paolo, et al.
Publicado: (2017)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
por: Huang, Luo, et al.
Publicado: (2020)

Management of recurrent nasopharyngeal carcinoma: current perspectives
por: Perri, F, et al.
Publicado: (2019)

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015)

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
por: Tan, Laura Ling Ying, et al.
Publicado: (2021)

Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells
por: Daker, Maelinda, et al.
Publicado: (2012)

Prognostic role of resection margin in open oncologic laryngeal surgery: survival analysis of a cohort of 139 patients affected by squamous cell carcinoma()
por: Saraniti, Carmelo, et al.
Publicado: (2018)

Nasopharyngeal Carcinoma Metastatic to the Mandible
por: Huang, Po Hsien, et al.
Publicado: (2010)

Adjunctive PD-1 inhibitor versus standard chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Polintan, Edgar Theodore, et al.
Publicado: (2022)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis
por: Peng, Pei-Jian, et al.
Publicado: (2014)

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
por: Chia, Whay-Kuang, et al.
Publicado: (2014)

Molecular Targeted Therapy in the Management of Recurrent and Metastatic Nasopharyngeal Carcinoma: A Comprehensive Literature Review
por: Almobarak, Abdulaziz A, et al.
Publicado: (2019)

Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Jin, Ting, et al.
Publicado: (2020)

Are PD-1 inhibitors effective for recurrent/metastatic nasopharyngeal carcinoma? Meta-analysis and systematic review
por: Yan, Le, et al.
Publicado: (2023)

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer
por: Pei, Zhengda, et al.
Publicado: (2023)

Recurrent Herpes Zoster Ophthalmicus Preceded by Anabolic Steroids and High-Dose L-Arginine
por: LoBue, Stephen A., et al.
Publicado: (2020)

Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis
por: Valerio, Maria Rosaria, et al.
Publicado: (2021)

Recurrent herpes zoster ophthalmicus in a young, healthy individual taking high doses of l-Arginine
por: LoBue, Stephen A., et al.
Publicado: (2019)

Neoantigen landscape in metastatic nasopharyngeal carcinoma
por: Lin, Mei, et al.
Publicado: (2021)

Prognostic factors in metastatic nasopharyngeal carcinoma
por: Toumi, Nabil, et al.
Publicado: (2020)

Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
por: Yang, Yunpeng, et al.
Publicado: (2021)

Gemcitabine Combined with Cisplatin Has a Better Effect in the Treatment of Recurrent/Metastatic Advanced Nasopharyngeal Carcinoma
por: Yang, Qiao, et al.
Publicado: (2022)

The efficacy and safety of apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Lin, Huixiong, et al.
Publicado: (2022)

Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023)

Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma
por: Secondino, Simona, et al.
Publicado: (2023)

Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report
por: Takayoshi, Kotoe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l3d0utko3o657enakdp8mnl7bf